Alto Neuroscience, Inc.
ANRONYSEHealthcare● Active
$18.77
+$0.53(+2.88%)
Market Cap$658537784
P/E Ratio—
52W High$28.441
52W Low$2.15
Alto Neuroscience, Inc.（ANRO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ANRO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.06B) | ($0.06B) | ($0.04B) | ($0.03B) | ($0.01B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | $0.00B | ($0.00B) | $0.00B | ($0.00B) |
| Net Cash from Operations | ($0.05B) | ($0.05B) | ($0.03B) | ($0.02B) | ($0.01B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.01B | $0.00B | $0.00B | $0.01B | $0.00B |
| Net Cash from Financing | $0.06B | $0.14B | $0.07B | $0.04B | $0.03B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.05B) | ($0.05B) | ($0.03B) | ($0.02B) | ($0.01B) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Alto Neuroscience, Inc.
关于Alto Neuroscience, Inc.（ANRO）现金流量表
Alto Neuroscience, Inc. 2025财年经营活动现金流($0.05B)，自由现金流($0.05B)（FCF利润率—），资本支出($0.00B)。
常见问题
ANRO · 4 问Alto Neuroscience, Inc. 2025财年自由现金流($0.05B)，同比down4.6%。
ANRO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10